SCHEMBL6956152

SCHEMBL6956152

CC1(C)CNCC(C)(C)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.41
HTR2C P28335 3/20 0.41
CYP3A4 P08684 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALOX15 P16050 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
BCHE P06276 1/20 0.37
CHRM5 P08912 1/20 0.37
TSHR P16473 1/20 0.37
ALOX12 P18054 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
PRCP P42785 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL329676 0.80 HTR2A (0.42) HTR2AHTR2CCYP3A4MEN1CYP2D6
SCHEMBL29588076 0.80 HTR2A (0.42) HTR2AHTR2CCYP3A4MEN1CYP2D6
Hydrochloric Acid SCHEMBL550115 0.78 HTR2C (0.41) HTR2AHTR2CCYP3A4MEN1CYP2D6
SCHEMBL9058489 0.77 HTR2A (0.62) HTR2AHTR2CCYP3A4MEN1CYP2D6
SCHEMBL29608943 0.75 RXRA (0.42) HTR2A
SCHEMBL501768 0.75 RXRA (0.42) HTR2A
SCHEMBL30695310 0.75 HTR2A (0.39) HTR2APDK2PDK4
SCHEMBL2353102 0.75 HTR2A (0.39) HTR2APDK2PDK4
SCHEMBL29384370 0.73 PDK2 (0.42) HTR2AHTR2CPDK2PDK4
SCHEMBL1031209 0.73 PDK2 (0.42) HTR2AHTR2CPDK2PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed